Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-050143

Options or other derivatives

  • PRESIDENT & CFO acquired 135,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
MORTIMER IAN PRESIDENT & CFO 2019-09-16 Grant or award · Stock Option (Right to Buy) +135,000 135,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…